Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis limits use of Copaxone rival Gilenya
Globes, Israel
Sunday, April 22, 2012 - 1:31pm
tags:
Novartis, Teva Pharmaceuticals, Gilenya, Copaxone, multiple sclerosis
China Biotech In Review: Fidelity Starts New VC Fund For China Healthcare
Seeking Alpha
Sunday, April 22, 2012 - 1:28pm
tags:
Fidelity Investments, Daiichi Sankyo, Shanghai Xinshengyuan, Luqa Pharma, Ebernet
D.C. Week: Court Sides with Generic Makers
MedPage Today
Sunday, April 22, 2012 - 12:44pm
tags:
FDA, generics
Iris Pharma, RxGen team-up to offer ophthalmology research to pharma & biotech companies
Pharmabiz
Sunday, April 22, 2012 - 12:28pm
tags:
Iris Pharma, RxGen, CROs
Presidio Pharmaceuticals Announces a New Clinical Candidate, PPI-383, a Novel Pan-Genotypic Non-Nucleoside Polymerase Inhibitor for HCV
Pipeline Review
Sunday, April 22, 2012 - 12:25pm
tags:
Presidio, PPI-383, hepatitis C
Endocyte Scores With Merck Partnership
Seeking Alpha
Sunday, April 22, 2012 - 12:13pm
tags:
Endocyte, Merck, vintafolide, ovarian cancer, non-small cell lung cancer
U.S FDA says focused on tracking drugs after approval
Reuters
Sunday, April 22, 2012 - 12:07pm
tags:
FDA
Roche talks to Illumina rivals after drops bid: paper
Yahoo/Reuters
Sunday, April 22, 2012 - 12:06pm
tags:
Roche, Illumina, M&A
Human Genome Sciences Is Now A Serious Buyout Story To Watch
Seeking Alpha
Sunday, April 22, 2012 - 12:04pm
tags:
Human Genome Sciences, M&A
Gilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All Oral' Combinations
Seeking Alpha
Sunday, April 22, 2012 - 12:04pm
tags:
Gilead Sciences, GS-7977, hepatitis C
Gilead, Bristol Shine at EASL Conference
Motley Fool
Sunday, April 22, 2012 - 12:02pm
tags:
Gilead Sciences, Bristol-Myers Squibb, GS-7977, daclatasvir, hepatitis C
GlaxoSmithKline sells more noncore brands
BusinessWeek
Saturday, April 21, 2012 - 1:27pm
tags:
GSK
Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement
4-Traders
Saturday, April 21, 2012 - 1:26pm
tags:
Biostar Pharmaceuticals
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
Enhanced Online News
Saturday, April 21, 2012 - 1:24pm
tags:
Ferumoxytol, Amag Pharmaceuticals, anemia, chronic kidney disease
Analysts And Investors Are Too Excited About The SXC Health Solutions Deal
Seeking Alpha
Saturday, April 21, 2012 - 1:04pm
tags:
SXC Health Solutions, Catalyst Health Solutions, M&A
Abbott Presents Positive Results From Phase 2 "Pilot" Study Of An Interferon-Free Combination Regimen For The Treatment Of Hepatitis C
Pharmaceutical Online
Saturday, April 21, 2012 - 1:03pm
tags:
Abbott Laboratories, ABT-072, ABT-450, hepatitis C
Eli Lilly & Co. First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Saturday, April 21, 2012 - 1:00pm
tags:
Eli Lilly, earnings
Celebrate the Hep C Wins, for Now
Motley Fool
Saturday, April 21, 2012 - 12:26pm
tags:
hepatitis C, Gilead Sciences, GS-7977, daclatasvir, Bristol-Myers Squibb, Abbott Laboratories, Vertex Pharmaceuticals, Incivek
Cure Worms, Make Money
Motley Fool
Saturday, April 21, 2012 - 12:24pm
tags:
GSK, tropical diseases, Novartis, Pfizer, Abbott Laboratories, JNJ
Danone hikes Pfizer unit bid
Yahoo/Investor's Business Daily
Saturday, April 21, 2012 - 12:21pm
tags:
Danone, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.